EYELID ILLUMINATION SYSTEMS AND METHODS FOR IMAGING MEIBOMIAN GLANDS FOR MEIBOMIAN GLAND ANALYSIS

    公开(公告)号:US20220022741A1

    公开(公告)日:2022-01-27

    申请号:US17498102

    申请日:2021-10-11

    Abstract: Eyelid illumination systems and methods for imaging meibomian glands for meibomian gland analysis are disclosed. In one embodiment, a patient's eyelid is IR trans-illuminated with an infrared (IR) light. A trans-illumination image of the patient's eyelid is captured, showing meibomian glands in dark outlined areas, whereas non-gland material is shown in light areas. This provides a high contrast image of the meibomian glands that is X-ray-like. The lid trans-illumination image of the meibomian glands can be analyzed to determine to diagnose the meibomian glands in the patient's eyelid. The eyelid may be trans-illuminated by a lid-flipping device configured to grasp and flip the eyelid for imaging the interior surface of the eyelid. Also, an IR surface meibography image of the meibomian glands may also be captured and combined with the trans-illumination image of the meibomian glands to provide a higher contrast image of the meibomian glands.

    EYELID ILLUMINATION SYSTEMS AND METHODS FOR IMAGING MEIBOMIAN GLANDS FOR MEIBOMIAN GLAND ANALYSIS

    公开(公告)号:US20190209014A1

    公开(公告)日:2019-07-11

    申请号:US16355039

    申请日:2019-03-15

    CPC classification number: A61B5/0082 A61B5/0077 A61B5/6821

    Abstract: Eyelid illumination systems and methods for imaging meibomian glands for meibomian gland analysis are disclosed. In one embodiment, a patient's eyelid is IR trans-illuminated with an infrared (IR) light. A trans-illumination image of the patient's eyelid is captured showing meibomian glands in dark outlined areas, whereas non-gland material is shown in light areas. This provides a high contrast image of the meibomian glands that is X-ray like. The lid trans-illumination image of the meibomian glands can be analyzed to determine to diagnose the meibomian glands in the patient's eyelid. The eyelid may be trans-illuminated by a lid-flipping device configured to grasp and flip the eyelid for imaging the interior surface of the eyelid. Also, an IR surface meibography image of the meibomian glands may also be captured and combined with the trans-illumination image of the meibomian glands to provide a higher contrast image of the meibomian glands.

    APPARATUSES AND METHODS FOR DIAGNOSING AND/OR TREATING LIPID TRANSPORT DEFICIENCY IN OCULAR TEAR FILMS, AND RELATED COMPONENTS AND DEVICES
    18.
    发明申请
    APPARATUSES AND METHODS FOR DIAGNOSING AND/OR TREATING LIPID TRANSPORT DEFICIENCY IN OCULAR TEAR FILMS, AND RELATED COMPONENTS AND DEVICES 审中-公开
    用于诊断和/或治疗眼泪膜中的脂质运输缺陷的装置和方法,以及相关组件和装置

    公开(公告)号:US20150216725A1

    公开(公告)日:2015-08-06

    申请号:US14422948

    申请日:2013-08-22

    Abstract: Methods and apparatuses are disclosed for the diagnosis and removal of the devitalized and/or dead cell material formed in the lid margin to attempt to restore a normal lid margin. In this manner, the devitalized and/or dead cell material are removed or the amount present is reduced or no longer present to prevent, reduce, or affect the transport of lipid secreted by the meibomian glands to the tear film to reduce evaporative dry eye and improve dry eye conditions in patients. The diagnosis and removal of devitalized and/or dead cell material may be performed at desired intervals. Patients that suffer from conditions that block meibomian gland orifices, partial, infrequent, or inhibited blinking resulting in reduced lipid secretions from meibomian glands, and/or blockages in meibomian gland channels reducing secretion of lipids through the meibomian gland orifices may require more frequent diagnosis and treatment to remove devitalized and/or dead cell material.

    Abstract translation: 公开了用于诊断和去除在盖边缘中形成的失活的和/或死细胞材料以尝试恢复正常盖边缘的方法和装置。 以这种方式,去除失活的和/或死细胞材料,或者减少或不再存在量以防止,减少或影响由睑板腺分泌的脂质转移到泪膜以减少蒸发干眼, 改善患者的干眼症状。 可以以期望的间隔进行失活和/或死细胞材料的诊断和去除。 患有阻塞睑板腺腺泡,部分,不频繁或抑制性眨眼,导致睑板腺脂肪分泌减少和/或睑板腺通道阻塞的病症的患者减少通过睑板腺腺泡分泌脂质可能需要更频繁的诊断和 处理以除去失活的和/或死细胞材料。

Patent Agency Ranking